3 June 2019 ORYZON to present first clinical data from ALICE Phase IIa trial with iadademstat at the 24th Congress of the European Hematology Association
29 May 2019 ORYZON announces First Patient in the US in ETHERAL-US: a Phase IIa clinical trial with vafidemstat in Alzheimer’s Disease
25 April 2019 ORYZON to present vafidemstat efficacy data at the 7th World Congress on ADHD in Lisbon
15 April 2019 ORYZON to present further REIMAGINE efficacy data with vafidemstat at the 7th World Congress on ADHD in Lisbon
8 April 2019 ORYZON to present first in human efficacy data with Vafidemstat at the 27th European Congress of Psychiatry in Warsaw